跳至主要内容
临床试验/NCT04937712
NCT04937712Unknown不适用

Molecular Characterization and Cellular Infection Capacity of Urinary Viral Particles Isolated From SARS-CoV-2 and Association With Proximal Tubular Dysfunction, in Hospitalized Patients With COVID-19

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2021年8月19日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
34
试验地点
1
主要终点
SARS-CoV 2 viruria and its correlation with proximal tubule dysfunction

研究概览

简要总结

The primary goal is to detect Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) urine viral particles in patients in intensive care units, hospitalized for coronavirus Coronavirus Disease-19 (COVID-19) infection, and correlate the presence of the virus in the urine with proximal tubular dysfunction (defined by the association of at least 2 abnormalities: tubular proteinuria, renal phosphate leak, uricosuria, normoglycemic glycosuria, amino aciduria)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Person and / or trustworthy person who has received complete information on the organization of the research and who has not opposed their participation and the use of their data
  • Hospitalized for ≥ 48 hours and ≤ 10 days
  • SARS-CoV-2 positive nasopharyngeal sample
  • Severity criteria: Lung involvement described as compatible with SARS-CoV-2 on radiography or scanner and partial pressure of oxygne (PaO2) / Fraction of inspired oxygen (FiO2) ≤ 300 mmHg and / or respiratory rate (RR) ≥ 30 / min

排除标准

  • Known chronic kidney disease, or initial Glomerular Filtration Rate (GFR) <60 ml / min / 1.73m2 or Renal Transplant
  • Known proteinuria
  • Known proximal tubulopathy
  • Treatment with Forxiga

结局指标

主要结局

SARS-CoV 2 viruria and its correlation with proximal tubule dysfunction

时间窗: During the first 10 days of hospitalization

Is the detection of viral particles in urine associated with proximal tubule dysfunction, defined by two or more of the following : proteinuria, phosphate leak, aminoaciduria, hyperuricuria, and/or glycosuria

次要结局

  • Capacity of infection of urine viral particles(During the first 10 days of hospitalization)
  • Sequencing viral particles to identify possible compartmentalization of the virus(During the first 10 days of hospitalization)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

Raphaël KORMANN

Principal investigator, Medical Doctor, Nephrologist

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验